• レポートコード:GIR-105X12229 • 出版社/出版日: / 2021年5月 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:Pharma & Healthcare |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ナファレリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ナファレリンの種類別市場規模(点鼻薬、冷凍乾燥粉末)、用途別市場規模(中枢性思春期早発症、子宮内膜症)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ナファレリンの市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Pfizer、Shanghai Soho-Yiming Pharmaceuticals、CPC Scientific、Hangzhou Longshine Bio-Tech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:点鼻薬、冷凍乾燥粉末 ・用途別分析2016年-2026年:中枢性思春期早発症、子宮内膜症 ・ナファレリンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・ナファレリンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・ナファレリンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・ナファレリンの南米市場規模2016年-2026年:ブラジル、アルゼンチン ・ナファレリンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nafarelin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nafarelin size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Nafarelin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nafarelin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nasal Spray
Freeze-dried Powder
Market segment by Application can be divided into
Central Precocious Puberty
Endometriosis
The key market players for global Nafarelin market are listed below:
Pfizer
Shanghai Soho-Yiming Pharmaceuticals
CPC Scientific
Hangzhou Longshine Bio-Tech
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Nafarelin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nafarelin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Nasal Spray
1.2.3 Freeze-dried Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Nafarelin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Central Precocious Puberty
1.3.3 Endometriosis
1.4 Global Nafarelin Market Size & Forecast
1.4.1 Global Nafarelin Sales in Value (2016-2026))
1.4.2 Global Nafarelin Sales in Volume (2016-2026)
1.4.3 Global Nafarelin Price by Type (2016-2026) & (USD/mg)
1.5 Global Nafarelin Production Capacity Analysis
1.5.1 Global Nafarelin Total Production Capacity (2016-2026)
1.5.2 Global Nafarelin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nafarelin Market Drivers
1.6.2 Nafarelin Market Restraints
1.6.3 Nafarelin Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Nafarelin Product and Services
2.1.4 Pfizer Nafarelin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Shanghai Soho-Yiming Pharmaceuticals
2.2.1 Shanghai Soho-Yiming Pharmaceuticals Details
2.2.2 Shanghai Soho-Yiming Pharmaceuticals Major Business
2.2.3 Shanghai Soho-Yiming Pharmaceuticals Nafarelin Product and Services
2.2.4 Shanghai Soho-Yiming Pharmaceuticals Nafarelin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CPC Scientific
2.3.1 CPC Scientific Details
2.3.2 CPC Scientific Major Business
2.3.3 CPC Scientific Nafarelin Product and Services
2.3.4 CPC Scientific Nafarelin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Hangzhou Longshine Bio-Tech
2.4.1 Hangzhou Longshine Bio-Tech Details
2.4.2 Hangzhou Longshine Bio-Tech Major Business
2.4.3 Hangzhou Longshine Bio-Tech Nafarelin Product and Services
2.4.4 Hangzhou Longshine Bio-Tech Nafarelin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Nafarelin Sales by Manufacturer
3.1 Global Nafarelin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nafarelin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nafarelin
3.4 Market Concentration Rate
3.4.1 Top 3 Nafarelin Manufacturer Market Share
3.4.2 Top 6 Nafarelin Manufacturer Market Share
3.5 Global Nafarelin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nafarelin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nafarelin Market Size by Region
4.1.1 Global Nafarelin Sales in Volume by Region (2016-2026)
4.1.2 Global Nafarelin Revenue by Region (2016-2026)
4.2 North America Nafarelin Revenue (2016-2026)
4.3 Europe Nafarelin Revenue (2016-2026)
4.4 Asia-Pacific Nafarelin Revenue (2016-2026)
4.5 South America Nafarelin Revenue (2016-2026)
4.6 Middle East and Africa Nafarelin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nafarelin Sales in Volume by Type (2016-2026)
5.2 Global Nafarelin Revenue by Type (2016-2026)
5.3 Global Nafarelin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nafarelin Sales in Volume by Application (2016-2026)
6.2 Global Nafarelin Revenue by Application (2016-2026)
6.3 Global Nafarelin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nafarelin Sales by Type (2016-2026)
7.2 North America Nafarelin Sales by Application (2016-2026)
7.3 North America Nafarelin Market Size by Country
7.3.1 North America Nafarelin Sales in Volume by Country (2016-2026)
7.3.2 North America Nafarelin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nafarelin Sales by Type (2016-2026)
8.2 Europe Nafarelin Sales by Application (2016-2026)
8.3 Europe Nafarelin Market Size by Country
8.3.1 Europe Nafarelin Sales in Volume by Country (2016-2026)
8.3.2 Europe Nafarelin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nafarelin Sales by Type (2016-2026)
9.2 Asia-Pacific Nafarelin Sales by Application (2016-2026)
9.3 Asia-Pacific Nafarelin Market Size by Region
9.3.1 Asia-Pacific Nafarelin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nafarelin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nafarelin Sales by Type (2016-2026)
10.2 South America Nafarelin Sales by Application (2016-2026)
10.3 South America Nafarelin Market Size by Country
10.3.1 South America Nafarelin Sales in Volume by Country (2016-2026)
10.3.2 South America Nafarelin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nafarelin Sales by Type (2016-2026)
11.2 Middle East & Africa Nafarelin Sales by Application (2016-2026)
11.3 Middle East & Africa Nafarelin Market Size by Country
11.3.1 Middle East & Africa Nafarelin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nafarelin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nafarelin Typical Distributors
12.3 Nafarelin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nafarelin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nafarelin Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Nafarelin Product and Services
Table 6. Pfizer Nafarelin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Shanghai Soho-Yiming Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Shanghai Soho-Yiming Pharmaceuticals Major Business
Table 9. Shanghai Soho-Yiming Pharmaceuticals Nafarelin Product and Services
Table 10. Shanghai Soho-Yiming Pharmaceuticals Nafarelin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 12. CPC Scientific Major Business
Table 13. CPC Scientific Nafarelin Product and Services
Table 14. CPC Scientific Nafarelin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hangzhou Longshine Bio-Tech Basic Information, Manufacturing Base and Competitors
Table 16. Hangzhou Longshine Bio-Tech Major Business
Table 17. Hangzhou Longshine Bio-Tech Nafarelin Product and Services
Table 18. Hangzhou Longshine Bio-Tech Nafarelin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Nafarelin Sales by Manufacturer (2019-2021e) & (g)
Table 20. Global Nafarelin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Nafarelin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Nafarelin Production Capacity by Company, (g): 2020 VS 2021
Table 23. Head Office and Nafarelin Production Site of Key Manufacturer
Table 24. Global Nafarelin Sales by Region (2016-2021e) & (g)
Table 25. Global Nafarelin Sales by Region (2021-2026) & (g)
Table 26. Global Nafarelin Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Nafarelin Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Nafarelin Sales by Type (2016-2021e) & (g)
Table 29. Global Nafarelin Sales by Type (2021-2026) & (g)
Table 30. Global Nafarelin Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Nafarelin Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Nafarelin Price by Type (2016-2021e) & (USD/mg)
Table 33. Global Nafarelin Price by Type (2021-2026) & (USD/mg)
Table 34. Global Nafarelin Sales by Application (2016-2021e) & (g)
Table 35. Global Nafarelin Sales by Application (2021-2026) & (g)
Table 36. Global Nafarelin Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Nafarelin Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Nafarelin Price by Application (2016-2021e) & (USD/mg)
Table 39. Global Nafarelin Price by Application (2021-2026) & (USD/mg)
Table 40. North America Nafarelin Sales by Country (2016-2021e) & (g)
Table 41. North America Nafarelin Sales by Country (2021-2026) & (g)
Table 42. North America Nafarelin Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Nafarelin Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Nafarelin Sales by Type (2016-2021e) & (g)
Table 45. North America Nafarelin Sales by Type (2021-2026) & (g)
Table 46. North America Nafarelin Sales by Application (2016-2021e) & (g)
Table 47. North America Nafarelin Sales by Application (2021-2026) & (g)
Table 48. Europe Nafarelin Sales by Country (2016-2021e) & (g)
Table 49. Europe Nafarelin Sales by Country (2021-2026) & (g)
Table 50. Europe Nafarelin Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Nafarelin Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Nafarelin Sales by Type (2016-2021e) & (g)
Table 53. Europe Nafarelin Sales by Type (2021-2026) & (g)
Table 54. Europe Nafarelin Sales by Application (2016-2021e) & (g)
Table 55. Europe Nafarelin Sales by Application (2021-2026) & (g)
Table 56. Asia-Pacific Nafarelin Sales by Region (2016-2021e) & (g)
Table 57. Asia-Pacific Nafarelin Sales by Region (2021-2026) & (g)
Table 58. Asia-Pacific Nafarelin Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Nafarelin Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Nafarelin Sales by Type (2016-2021e) & (g)
Table 61. Asia-Pacific Nafarelin Sales by Type (2021-2026) & (g)
Table 62. Asia-Pacific Nafarelin Sales by Application (2016-2021e) & (g)
Table 63. Asia-Pacific Nafarelin Sales by Application (2021-2026) & (g)
Table 64. South America Nafarelin Sales by Country (2016-2021e) & (g)
Table 65. South America Nafarelin Sales by Country (2021-2026) & (g)
Table 66. South America Nafarelin Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Nafarelin Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Nafarelin Sales by Type (2016-2021e) & (g)
Table 69. South America Nafarelin Sales by Type (2021-2026) & (g)
Table 70. South America Nafarelin Sales by Application (2016-2021e) & (g)
Table 71. South America Nafarelin Sales by Application (2021-2026) & (g)
Table 72. Middle East & Africa Nafarelin Sales by Country (2016-2021e) & (g)
Table 73. Middle East & Africa Nafarelin Sales by Country (2021-2026) & (g)
Table 74. Middle East & Africa Nafarelin Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Nafarelin Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Nafarelin Sales by Type (2016-2021e) & (g)
Table 77. Middle East & Africa Nafarelin Sales by Type (2021-2026) & (g)
Table 78. Middle East & Africa Nafarelin Sales by Application (2016-2021e) & (g)
Table 79. Middle East & Africa Nafarelin Sales by Application (2021-2026) & (g)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Nafarelin Typical Distributors
Table 83. Nafarelin Typical Customers
List of Figures
Figure 1. Nafarelin Picture
Figure 2. Global Nafarelin Sales Market Share by Type in 2020
Figure 3. Nasal Spray
Figure 4. Freeze-dried Powder
Figure 5. Global Nafarelin Sales Market Share by Application in 2020
Figure 6. Central Precocious Puberty
Figure 7. Endometriosis
Figure 8. Global Nafarelin Market Size, (USD Million) & (g): 2020 VS 2021 VS 2026
Figure 9. Global Nafarelin Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Nafarelin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Nafarelin Sales (2016-2026) & (g)
Figure 30. Global Nafarelin Production Capacity (2016-2026) & (g)
Figure 31. Global Nafarelin Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Nafarelin Market Drivers
Figure 33. Nafarelin Market Restraints
Figure 34. Nafarelin Market Trends
Figure 35. Global Nafarelin Sales Market Share by Manufacturer in 2020
Figure 36. Global Nafarelin Revenue Market Share by Manufacturer in 2020
Figure 37. Nafarelin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Nafarelin Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Nafarelin Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Nafarelin Sales Market Share by Region (2016-2026)
Figure 41. Global Nafarelin Revenue Market Share by Region (2016-2026)
Figure 42. North America Nafarelin Revenue (2016-2026) & (USD Million)
Figure 43. Europe Nafarelin Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Nafarelin Revenue (2016-2026) & (USD Million)
Figure 45. South America Nafarelin Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Nafarelin Revenue (2016-2026) & (USD Million)
Figure 47. Global Nafarelin Sales Market Share by Type (2016-2026)
Figure 48. Global Nafarelin Revenue Market Share by Type (2016-2026)
Figure 49. Global Nafarelin Price by Type (2016-2026) & (USD/mg)
Figure 50. Global Nafarelin Sales Market Share by Application (2016-2026)
Figure 51. Global Nafarelin Revenue Market Share by Application (2016-2026)
Figure 52. Global Nafarelin Price by Application (2016-2026) & (USD/mg)
Figure 53. North America Nafarelin Sales Market Share by Country (2016-2026)
Figure 54. North America Nafarelin Revenue Market Share by Country (2016-2026)
Figure 55. North America Nafarelin Sales Market Share by Type (2016-2026)
Figure 56. North America Nafarelin Sales Market Share by Application (2016-2026)
Figure 57. Europe Nafarelin Sales Market Share by Country (2016-2026)
Figure 58. Europe Nafarelin Revenue Market Share by Country (2016-2026)
Figure 59. Europe Nafarelin Sales Market Share by Type (2016-2026)
Figure 60. Europe Nafarelin Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Nafarelin Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Nafarelin Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Nafarelin Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Nafarelin Sales Market Share by Application (2016-2026)
Figure 65. South America Nafarelin Sales Market Share by Country (2016-2026)
Figure 66. South America Nafarelin Revenue Market Share by Country (2016-2026)
Figure 67. South America Nafarelin Sales Market Share by Type (2016-2026)
Figure 68. South America Nafarelin Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Nafarelin Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Nafarelin Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Nafarelin Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Nafarelin Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source